Skip to content
Join Our Newsletter
Search for:
MENU
MENU
Latest
News & Opinions
Articles & Reports
Blog
Litigation/Enforcement
Cal Legislative Beat
Spotlight on State
Key Issues
Conditional Approval
Cross-Market Systems
Market Consolidation
Provider Contracts
Provider Rate Regulation
State Action
Legislative Update
SLIHCQ Database
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Litigation
Major Cases
Litigation Blog
Litigation Database
About
The Source Team
Source Sightings
Advisory Board
Join Our Newsletter
Latest
News & Opinions
Articles & Reports
Blog
Litigation/Enforcement
Cal Legislative Beat
Spotlight on State
Key Issues
Conditional Approval
Cross-Market Systems
Market Consolidation
Provider Contracts
Provider Rate Regulation
State Action
Legislative Update
SLIHCQ Database
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Louisiana
Indiana
Iowa
Kansas
Kentucky
Montana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Litigation
Major Cases
Litigation Blog
Litigation Database
About
The Source Team
Source Sightings
Advisory Board
Join Our Newsletter
Search
News & Opinions
Key Issues
All
--Antitrust Enforcement
--Healthcare Consolidation
--Private Equity
PHARMACEUTICALS
-Drug Pricing
-340B Drug Pricing Program
Jurisdiction
All
Federal
Colorado
Tennessee
Start Date
End Date
Lawmakers Target the Power of Health Insurance Giants
Reed Abelson, Rebecca Robbins
July 8, 2026
Why the 340B payment fight is flaring up again
Bridget Early
July 8, 2026
Independent pharmacies hit Prime Therapeutics with antitrust suit over alleged price fixing
Paige Minemyer
July 7, 2026
Ascension outbids HCA, Optum for Williamson Health
Alex Kacik
July 7, 2026
Private equity may skirt oversight with nonprofit healthcare joint ventures
Sydney Halleman
July 7, 2026
The strategies hospitals are using now to prepare for a tough 2027
Caroline Hudson
July 6, 2026
5,000 Pharmacies Accuse Prime Therapeutics Of Price-Fixing
Lauren Berg
July 6, 2026
U.S. judge blocks Colorado’s first-of-its-kind price cap on an Amgen drug
Ed Silverman
July 2, 2026
Congress eyes boost to direct contracting, cutting out insurers
Michael McAuliff
July 2, 2026
The newest weapon against insurer nonpayment — and its growing controversy
Francesca Mathewes
July 2, 2026
Tax-exempt hospitals targeted in bill demanding more disclosure
Michael McAuliff
July 1, 2026
Court dismisses PBMs’ lawsuit against FTC following insulin settlements
Rebecca Pifer Parduhn
July 1, 2026
Remedies, Not Suits: How FTC Approaches Health Mergers
Yeji Jesse Lee
June 30, 2026
Congress looks to drag healthcare private equity into the light
Michael McAuliff
June 30, 2026
Health systems shift toward outpatient deals as M&A evolves
Alex Kacik
June 30, 2026
Insulin Makers Can’t Nix 340B Antitrust Claims On Remand
Gianna Ferrarin
June 29, 2026
Next
Previous
5
6
7
Next
Page load link
Go to Top
